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Abstract: Leonardo da Vinci was born in Italy. Among the researchers and scientists, he is favourably known for his 
remarkable efforts in scientific work. His investigations of atherosclerosis judiciously combine three separate fields of 
research. In 1506, he finished his masterpiece, painting of Mona Lisa. A careful clinical examination of the famous 
painting reveals a yellow irregular leather-like spot at the inner end of the left upper eyelid and a soft bumpy well-defined 
swelling of the dorsum of the right hand beneath the index finger about 3 cm long. This is probably the first case of 
familial hypercholesterolemia (FH). The FH code of Leonardo da Vinci was given immense consideration by scientists 
like Carl Muller, who described the xanthomas tuberosum and angina pectoris. On the contrary, Akira Endo searched for 
microbial metabolites that would inhibit HMG-CoA reductase, the rate-limiting enzyme in the synthesis of cholesterol and 
finally, Michael Brown and Joseph Goldstein published a remarkable series of elegant and insightful papers in the 70s and 
80s. They established that the cellular uptake of low-density lipoprotein (LDL) essentially requires the LDL receptor. In 
conclusion: this was the real Code of Leonardo da Vinci.  
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INTRODUCTION 
  Leonardo da Vinci was a famous Italian artist, inventor 
and scientist born in Italy in 1452 and died in France in 1519 
at the age of 67. Leonardo da Vinci’s description of ather-
osclerosis is well known [1]. His scientific work is most 
remarkable in his multilateral approach to the problem. His 
investigations of atherosclerosis are no exception, which 
present a clear-cut description by combining three separate 
fields of research. Firstly, his study of hydrodynamics paved 
the way to bring to light various factors governing the flow 
of fluid. Secondly, the study of anatomy delineated his 
observations on the effects of age on anatomical structures, 
particularly on blood vessels. Thirdly, his concept of nutri-
tion, added a final touch to his description of the process. 
The thickening of the arterial wall pointed out the difference 
between the vessels in the young and in the old. As the 
vessels become old, their branches loose their structure and 
become much more tortuous, resulting in thickening of the 
walls. Leonardo, however, noticed that it is not the thic-
kening of the blood that hampers flow through the vessels, as 
the blood in the vessels does not thicken, because the old 
blood is continuously replaced with the new blood.  
  In 1503, Leonardo started the painting of Madonna Lisa 
Maria de Gherardini born in Florence in 1479 and died at the 
age of 37 (Fig. 1). He worked on the painting for 4 years. A 
careful clinical examination of the famous painting reveals a 
yellow irregular leather-like spot at the inner end of the left 
upper eyelid (Fig. 2) and a soft bumpy well-defined swelling 
of the dorsum of the right hand beneath the index finger 
about 3 cm long (Fig. 3). An infrared detailed photograph 
published in 1974 reveals that the yellow skin alteration was 
an integral part of the painting at the time of its initiation [2]. 
The yellow spot looked somewhat similar to what later came 
to be known as xanthelasma. These skin lesions are often  
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Fig. (1). Madonna Lisa Maria de Gherardini (Mona Lisa) 1479-
1516 painted by Leonardo da Vinci in 1503-1506. The painting is 
in Louvre, Paris.
observed in people suffering from inherited forms of 
hyperlipidemia. 
  Visual arts, particularly of the Flemish School, in com-
bination with historical documentation have been an impor-
tant tool for learning observational acuity in rheumatology 
and various skin disorders. An observation of xanthelasma in 
the eye region in association with subcutaneous lipoma of 
the dorsum of the hand in women between the age of 25 and 
40 may indicate early diagnosis of the metabolic disorder - 
hyperlipidemia - that may later be described as being fami-Code of FH  Current Cardiology Reviews, 2008, Vol. 4, No. 1    61
liar. The stronger evidence is supposed to be the observation 
of a corneal arcus and it was however not found in this 
portrait. The occurrence of xanthelasma lipoma in a women 
aged 25-30 is probably not coincidental. Mona Lisa died at 
the age of 37, but the cause of death could not be figured out. 
In conclusion, this portrait painted in 1506 is probably the 
first evidence of familial hypercholesterolemia (FH), which 
appeared long before a later description in 1852 by Addison 
and Gall. Frans Hals, the 17th century Dutch painter, again 
painted the xanthomas in an attempt to further elucidate the 
clinical disorder. This Portrait of an Elderly Lady of 1663, 
showed the classic lesions on the dorsum of the hand of a 60-
year old, who probably had heterozygous FH (Fig. 4, Fig. 5). 
The painting did not depict any traces of a history of 
manifestation of xanthelasma in that woman [3].  
  In 1873, Fagge described a case of xanthomastosis with 
cardiovascular symptoms and in 1889, Lehzen and Knaus 
reported the case of an 11-year-old girl presenting with the 
steadily growing xanthomas, accompanied by cardiovascular 
symptoms. She died suddenly and the post-mortem study 
revealed exanthomatous deposits in the aorta, with the 
narrowing isthmus, as in other large arteries. Later, her sister 
manifested similar skin changes, highlighting this case to be 
the first report on homozygous FH [4].  
  Francis Harbitz from Norway published several papers 
from 1920 to 1927 elucidating on the tumours of tendons 
sheets, joint capsules and ultimately the occurrence of 
multiple xanthomas, and sudden death. In all publications so 
far regarding hereditary xanthomatosis associated with heart 
disease, the authors did not pay significant attention to the 
condition due to being manifested infrequently [5]. 
  In 1937, almost 70 years ago, Carl Müller, identified the 
first patient ever who presented with xanthomas tuberosum 
and angina pectoris. Müller made a preliminary report of a 
number of cases in which he expressed that hypercholes-
terolemia is a frequent and important factor in heart disease, 
following which several new patients were referred to Müller 
and in 1939 he published his landmark paper [6]. He then 
reported on 17 families with 76 family members out of 
which 68 manifested symptoms of possible heart disease. 
Half of the patients died suddenly and xanthomas were noted 
alone or in combination with xanthelasma. Serum cholesterol 
level varied from 4 to 15 mmol/l. However, no correlation 
between levels of serum cholesterol and xanthomas or 
xanthelasma was observed. Müller noted that in xantho-
matosis, the vascular changes frequently manifested them-
selves in coronary disease and angina pectoris. In such a 
systemic disease one would expect other localizations of 
symptoms – however, he only came across a single case of 
death from stroke. He concluded his paper with the follo-
wing statement: "It has been shown that the cholesterol 
content of the blood can be reduced by a diet poor/low in 
cholesterol. I have ordered a diet with no yolk of eggs, 
butter, cream, fat milk or animal fat and thyroid tablets. I 
have not been able to formulate any opinion in regard of the 
effects. The treatment may be of prophylactic value to 
persons with hereditary predisposition". 
Fig. (4). Portrait of an Elderly Lady painted in 1633 by Frans Hals 
1580-1 - 1666. The painting is in the National Gallery of Art in 
Washington DC. 
Fig. (2). The painting of Mona Lisa revealed a yellow irregular 
leather-like spot at the inner end of the left upper eyelid. 
Fig. (3). A soft bumpy well-defined swelling is revealed on the 
dorsum of the right hand beneath the index finger being about 3 cm 
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Fig. (5). The Portrait of an Elderly Lady showed the classic lesions 
of xanthomas on the dorsum of the hand of a 60-year old lady.
  In 1971, Akira Endo started a project to search the 
microbial metabolites that would inhibit HMG-CoA 
reductase, the rate-limiting enzyme in the synthesis of 
cholesterol, with the intent that the suppression of the de 
novo cholesterol synthesis in the body by inhibiting HMG-
CoA reductase would reduce plasma cholesterol in humans. 
Over a 2-year period, about 6000 microbial strains were 
tested. A strain of Penicillum citrinum was found to produce 
active compounds and mevastatin was found [7]. Later, 
analogues of mevastatin were also found such as: lovastatin, 
simvastatin and pravastatin. 
  A remarkable series of elegant and insightful papers was 
published by Brown and Goldstein in the 70s and 80s. They 
established that the cellular uptake of low density lipoprotein 
(LDL) essentially requires the LDL receptor. In the complete 
absence of the LDL receptor, the LDL concentration in 
plasma can build up to 20-25 mmol/l. This discovery of the 
nature of the defective gene in familial hypercholesterolemia 
by Brown and Goldstein turned out to be a major milestone 
in the lipoprotein field and they were awarded the Nobel 
Price in Physiology and Medicine in 1985 [8]. The other 
forms of autosomal dominant hypercholesterolemia are 
familial defective apoB-100 which is caused by mutations in 
the apoB gene [9] and FH3, which is caused by mutations in 
the proprotein convertase subtilisin/kexin type 9 (PCK9) 
gene [10]. In addition to the dominant hypercholesterolemia, 
there is one autosomal recessive form caused by mutations in 
the LDL receptor adaptor protein [11]. 
  The real Code of da Vinci - is the code for FH. The first 
case was presented 500 years ago by Leonardo da Vinci in 
his painting of Mona Lisa and its solution was found through 
the work of scientists like Müller, Endo, Brown and Gold-
stein. 
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